News

Stifel Nicolaus analyst Daniel Arias maintained a Buy rating on Agilent Technologies, Inc. (NYSE:A) and set a price target of ...
On May 29, 2025, Stifel analysts reiterated their Buy rating and $550 price target for Synopsys, Inc. (NASDAQ:SNPS) shares.
On May 24, analysts at Stifel reaffirmed their Buy rating and price target of $48 for Bicara Therapeutics Inc. (NASDAQ:BCAX).
and on Friday a three-person arbitration panel ruled Stifel Nicolaus & Co. Inc. pay $7 million in legal costs of advisors who left the firm in 2023 and then were sued by the firm. It’s the ...